Jagsonpal Pharmaceuticals Limited has announced a significant employee stock option grant, with its board committee approving the allocation of 11,52,500 stock options to employees under the company's established ESOP framework.

Board Committee Approval

The Nomination and Remuneration Committee of the Board of Directors approved the employee stock option grant during their meeting held on March 09, 2026. The decision represents a substantial allocation under the Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan, 2022.

ESOP Grant Details

The key parameters of the stock option grant are structured as follows:

Vesting Structure

The granted stock options will follow a systematic vesting schedule designed to retain talent over multiple years. The options are convertible into an equivalent number of equity shares of Rs. 2.00 each. The vesting structure includes:

• Vesting Period: 4 equal annual tranches
• Commencement: First anniversary of the grant date
• Annual Allocation: Approximately 2,88,125 options per tranche

Corporate Communication

The company has formally communicated this development to both major stock exchanges where its shares are listed. Company Secretary and Compliance Officer Pratham Rawal signed the intimation letter, ensuring regulatory compliance and transparency with stakeholders.

This ESOP grant reflects the company's commitment to employee retention and alignment of workforce interests with long-term corporate performance objectives.

Jagsonpal Pharmaceuticals has completed the allotment of 71,800 equity shares under its Employee Stock Option Plan 2022 following the exercise of vested options by eligible employees. The Nomination and Remuneration Committee approved this allotment on March 09, 2026, resulting in an increase in the company's paid-up share capital.

Share Allotment Details

The latest ESOP allotment represents the successful exercise of employee stock options under the company's established equity participation program.

Capital Structure Impact

The allotment has resulted in a measurable increase in the company's equity base and paid-up share capital.

ESOP Program Background

The company previously granted 11,52,500 employee stock options under the same ESOP 2022 plan at an exercise price of Rs. 139.00 per option. The current allotment of 71,800 shares represents the exercise of vested options by employees who met the eligibility criteria under the four-year vesting schedule.

Regulatory Compliance

Jagsonpal Pharmaceuticals has fulfilled all regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has informed both BSE Limited and National Stock Exchange of India Limited about the share allotment.

The newly allotted shares rank pari-passu with existing equity shares in all respects, with no lock-in restrictions applicable. This ESOP exercise demonstrates the company's commitment to employee participation in equity ownership and long-term value creation.